MedTrace Logo

Trevo® Retriever Registry (China)

NCT03554850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2022-05-27

Study results available
· View outcomes & findings →

Summary

Trevo® Retriever Registry (China) is to assess real world performance of the FDA cleared Trevo Retriever intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke in China.

Conditions

  • Real World Data in China

Interventions

DEVICE

Trevo® Retriever

Stent retriever procedure

Sponsors & Collaborators

  • Stryker Neurovascular

    lead INDUSTRY

Principal Investigators

  • ZhongRong Miao, MD · Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-30
Primary Completion
2020-09-08
Completion
2021-02-02
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03554850 on ClinicalTrials.gov